Marken Healthtech Limited (Marken) Return Comparision with Primex 40 Index

Periods	1 Week	1 Month	3 Months	6 Months	1 Year	3 Years	All Time
Primex-40
Marken Healthtech Limited

Marken Healthtech Limited Standalone Balance Sheet (Rs in crores)

Particulars	31-03-2025
Equity
Share Capital	5.81
Reserves & Surplus	21.63
Non-Current Liabilities
Long-Term Borrowings	65.52
Long-Term Provisions	3.84
Current Liabilities
Trade Payables	25.80
Other Current Liabilities	0.76
Total Equity & Liabilities	123.36
Non-Current Assets
Tangible Assets	8.39
Intangible Assets	0.08
Non-Current Investments	0.75
Long-Term Loans & Advances	24.71
Other Non-Current Assets	5.39
Current Assets
Inventories	27.57
Trade Receivables	50.72
Cash & Bank Balances	0.18
Other Current Assets	5.57
Total Assets	123.36

Marken Healthtech Limited Standalone Profit & Loss Statement (Rs in Crores)

Particulars	31-03-2025
Revenue from Operations
Revenue from Sale of Products	118.41
Other Income	0.20
Total Revenue	118.61
Expenses
Cost of Materials Consumed	113.14
Changes in Inventories of Finished Goods, WIP & Stock-in-Trade	-27.55
Employee Benefit Expense	3.87
Finance Costs	0.39
Depreciation & Amortisation	0.30
Other Expenses	6.85
Total Expenses	97.00
Profit Before Exceptional Items & Tax	21.61
Exceptional Items	-11.25
Profit Before Tax	10.36
Current Tax	2.95
Profit After Tax	7.41
Earnings Per Share
Basic & Diluted	12.76

Marken Healthtech Limited Standalone Cash Flow Statement (Rs in crores)

Particulars	31.03.2025
Cash Flow from Operating Activities
Profit Before Tax	10.36
Adjustments:
Finance Costs	0.39
Depreciation & Amortisation	0.30
Other Adjustments	-0.13
Operating Profit before Working Capital Changes	10.92
Working Capital Changes:
Increase in Inventories	-27.55
Increase in Trade Receivables	-50.70
Increase in Other Current Assets	-35.67
Increase in Trade Payables	25.80
Increase in Other Current Liabilities	0.76
Increase in Provisions	3.84
Cash Generated from Operations	-72.60
Income Tax Paid	-2.95
Net Cash Flow from Operating Activities	-75.55
Cash Flow from Investing Activities
Purchase of Tangible Assets	8.77
Interest Received	0.13
Income taxes paid	-0.75
Net Cash Flow from Investing Activities	-9.39
Cash Flow from Financing Activities
Proceeds from Issue of Shares	20.00
Proceeds from Borrowings	65.52
Interest Paid	-0.39
Net Cash Flow from Financing Activities	85.13
Net Increase in Cash & Cash Equivalents	0.18
Cash & Cash Equivalents at the end of year	0.18

Summary of the Cash Flow Statement for the years 2025:

Cash Flow from Operating Activities

The company reported a net cash outflow of ₹75.55 crore from operating activities despite earning a Profit Before Tax of ₹10.36 crore. The primary reason was a substantial increase in working capital, particularly trade receivables (₹50.70 crore), inventories (₹27.55 crore), and other current assets (₹35.67 crore), which consumed significant cash. Although higher trade payables and provisions provided some support, they were insufficient to offset the large cash outflows. This indicates that a considerable amount of cash was tied up in business operations, resulting in weak operating cash generation during the year.

Cash Flow from Investing Activities

The company recorded a net cash outflow of ₹9.39 crore from investing activities. The outflow was mainly driven by capital expenditure of ₹8.77 crore on tangible assets, indicating continued investment in business infrastructure and capacity. A small amount of interest income (₹0.13 crore) partially offset the outflow. Overall, the investing cash flow reflects expansion or maintenance investments rather than asset disposals.

Cash Flow from Financing Activities

Financing activities generated a net cash inflow of ₹85.13 crore, primarily through ₹65.52 crore of borrowings and ₹20.00 crore raised from the issue of shares. These inflows were only marginally reduced by interest payments of ₹0.39 crore. The strong positive financing cash flow indicates that the company relied on external funding to finance its working capital requirements and capital investments during the year.

Net Cash Position

Despite significant cash outflows from operating and investing activities, the company ended the year with a net increase in cash and cash equivalents of ₹0.18 crore, supported entirely by financing inflows. The year-end cash balance remained modest at ₹0.18 crore, suggesting that while the company successfully raised sufficient funds to maintain liquidity, its operations were not yet generating positive cash flows. Going forward, improving working capital management—particularly the collection of receivables and inventory turnover—will be important to reduce dependence on external financing and strengthen cash generation.